Latest News & Updates
Breaking News
7 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Siren Biotechnology Becomes Clinical-Stage Company As FDA Approves IND For Its AAV-Based Cancer Therapy Targeting Recurrent High-Grade Glioma
Siren Biotechnology receives FDA IND clearance to begin first-in-human testing of its AAV immuno-gene therapy for glioma.
Simantini Singh Deo
Seamless Therapeutics Partners With Eli Lilly To Develop Programmable Recombinase Gene Therapies Targeting Genetic Hearing Loss, Potential Deal Over $1.12B
Seamless Therapeutics partners with Eli Lilly to advance programmable recombinase gene therapies targeting genetic hearing loss.
Simantini Singh Deo
Pacira BioSciences Appoints Samit Hirawat, M.D., To Board Of Directors, Expanding Board To 10 Members Amid Growth In Non-Opioid Pain Therapies
Pacira BioSciences appoints biopharma veteran Samit Hirawat, MD, to its Board of Directors as it advances non-opioid pain care.
Simantini Singh Deo
Life Biosciences Secures FDA Approval For ER-100, The First Cellular Rejuvenation Therapy Using Epigenetic Reprogramming To Enter Human Trials For Vision Loss
Life Biosciences receives FDA IND clearance for ER-100, launching first-in-human trials of a cellular rejuvenation therapy.
Simantini Singh Deo
